Pharmafile.com’s weekly COVID-19 news round-up
pharmafile | May 5, 2021 | News story | Research and Development | COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news
The past week has seen more COVID-19 vaccine and treatment news: Moderna will supply up to 500 million jabs to the COVAX worldwide vaccination programme, Celltrion’s treatment has shown promise against the South African variant of the virus, and a study has suggested that just a single dose of a vaccine may cut transmissions in half.
1. Moderna to supply up to 500 million COVID-19 vaccines to COVAX – Published 04/05/2021
Moderna have announced a supply agreement with Gavi, the Vaccine Alliance, for up to 500 million doses of their COVID-19 vaccine, including an initial 34 million doses to be delivered in the fourth quarter of 2021.
2. Celltrion’s COVID-19 treatment shows promise against South African variant – Published 30/04/21
Celltrion’s regdanvimab treatment for COVID-19 has shown itself to be effective against the South African variant of the virus, according to preliminary results from a pre-clinical trial.
3. Moderna up investments to produce 3 billion COVID vaccine doses in 2022 – Published 29/04/21
Moderna have announced it is making new funding commitments to increase supply at its owned and partnered manufacturing facilities, which it expects will increase global 2022 capacity to up to 3 billion doses of its COVID-19 vaccine.
4. COVID Symptom Study app reveals most common vaccine side effects – Published – 28/04/21
An analysis of over 600,000 people’s vaccine reports has been published in The Lancet Infectious Diseases journal, in the largest real-life study of COVID-19 vaccine side-effects in the world.
5. Single dose of COVID vaccine can cut transmissions in half – Published 28/04/21
A Public Health England (PHE) study into the Pfizer-BioNTech and Oxford-AstraZeneca vaccines has found that a single dose of either jab can cut COVID-19 transmissions by up to half.
Jack Goddard
Related Content
COVID-19 vaccine eligibility creates challenges for UK pharmacies
Pharmacists across England have reported widespread confusion among patients attempting to book COVID-19 vaccination appointments …
LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence
LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …
Mental health medicine use in England reaches record high, NHSBSA report reveals
According to new data published by the NHS Business Services Authority (NHSBSA), mental health prescriptions …
